Northwest Medical Specialties - Tacoma — Tacoma, Washington

Northwest Medical Specialties - Tacoma is a clinical research site located in Tacoma, Washington, United States 98405.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Northwest Medical Specialties - Tacoma has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Non-Squamous Non-Small Cell Lung Cancer, Breast Cancer Metastatic, Patients With Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc., Sanofi, OSE Immunotherapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tacoma

Browse all research sites in Washington · View every site in Tacoma

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Medical Specialties - Tacoma?

Northwest Medical Specialties - Tacoma has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Medical Specialties - Tacoma conducted?

Northwest Medical Specialties - Tacoma has 3 clinical trials on record, with 1 currently active. Their work covers Metastatic Non-Squamous Non-Small Cell Lung Cancer, Breast Cancer Metastatic, Patients With Non-Small Cell Lung Cancer.

Is Northwest Medical Specialties - Tacoma accredited by Crixeo Clinical Trials?

Northwest Medical Specialties - Tacoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwest Medical Specialties - Tacoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.